Literature DB >> 1623160

Effects of diazepam and D-amphetamine on rhythmic pattern of eye movements in goldfish.

C Salas1, F Navarro, B Torres, J M Delgado-Garcia.   

Abstract

The effects of diazepam and D-amphetamine on spontaneous, vestibular- and visually-induced eye movements were studied in the restrained goldfish. These animals showed a stereotyped pattern of spontaneous eye movements that scanned the visual field in the horizontal plane. Fourier analysis of these eye movements revealed a rhythmic pattern of about 5 cycles per minute, whose frequency increased to double and decreased to half following treatment with diazepam and D-amphetamine, respectively. However, the fast and slow components of vestibulo-ocular and optokinetic reflexes, as well as peculiar blink-like movements, remained unchanged at the same drug doses. These results suggest the presence of a central pattern generator for spontaneous eye movements in the goldfish, whose oscillation frequency is pharmacologically modifiable.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623160     DOI: 10.1097/00001756-199202000-00002

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Effects of diazepam on closed- and open-loop optokinetic nystagmus (OKN) in humans.

Authors:  Jing Tian; Min Wei; Pei-Ji Liang; Fuchuan Sun
Journal:  Exp Brain Res       Date:  2003-09-02       Impact factor: 1.972

2.  The effects of amphetamine injections on feeding behavior and the brain expression of orexin, CART, tyrosine hydroxylase (TH) and thyrotropin releasing hormone (TRH) in goldfish (Carassius auratus).

Authors:  Hélène Volkoff
Journal:  Fish Physiol Biochem       Date:  2012-12-11       Impact factor: 2.794

3.  Connectivity of the goldfish optic tectum with the mesencephalic and rhombencephalic reticular formation.

Authors:  M P Pérez-Pérez; M A Luque; L Herrero; P A Nunez-Abades; B Torres
Journal:  Exp Brain Res       Date:  2003-05-14       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.